MAYER, Jiří, Marta KREJČÍ, Zdeněk POSPÍŠIL, Michael DOUBEK, Andrea JANÍKOVÁ, Daniela ŽÁČKOVÁ, Zdeněk RÁČIL, Lenka ŠMARDOVÁ, Milan NAVRÁTIL and Jan KAMELANDER. Successful treatment of steroid-refractory hepatitic variant of liver graft-vs host disease with pulse cyclophosphamide. Experimental Hematology. 2009, vol. 37, No 6, p. 659-672. ISSN 0301-472X.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Successful treatment of steroid-refractory hepatitic variant of liver graft-vs host disease with pulse cyclophosphamide
Name in Czech Úspěšná léčba na steroidy rezistentní jaterní formy nemoci štěpu proti hostiteli pulsním cyklofosfamidem
Authors MAYER, Jiří, Marta KREJČÍ, Zdeněk POSPÍŠIL, Michael DOUBEK, Andrea JANÍKOVÁ, Daniela ŽÁČKOVÁ, Zdeněk RÁČIL, Lenka ŠMARDOVÁ, Milan NAVRÁTIL and Jan KAMELANDER.
Edition Experimental Hematology, 2009, 0301-472X.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30200 3.2 Clinical medicine
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 3.106
Organization unit Faculty of Medicine
UT WoS 000266458200002
Keywords in English steroid refractory hepatitic variant; pulse cyclophosphamide
Changed by Changed by: Jitka Drncová, učo 109799. Changed: 18/8/2009 09:58.
Abstract
Corticosteroid-resistant graft-vshost disease (GVHD) is difficult to manage and is associated with high morbidity and mortality. No standard treatment exists. We have previously seen good result with pulse cyclophosphamide (cy) in the treatment of liver GVHD in contrast to gastrointestinal GVHD, and here we report results of pulse Cy protocol in the treatment of steroid-refractory hepatitic variant of liver GVHD, with no association to the gut.
Abstract (in Czech)
Je to článek o úspěšné léčbě na steroidy rezistentní jaterní formy nemoci štěpu proti hostiteli pulsním cyklofosfamidem.
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 29/5/2024 19:10